• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浅表性膀胱癌:进展与复发

Superficial bladder cancer: progression and recurrence.

作者信息

Heney N M, Ahmed S, Flanagan M J, Frable W, Corder M P, Hafermann M D, Hawkins I R

出版信息

J Urol. 1983 Dec;130(6):1083-6. doi: 10.1016/s0022-5347(17)51695-x.

DOI:10.1016/s0022-5347(17)51695-x
PMID:6644886
Abstract

The tumors in 249 patients presenting initially with stages Ta and T1 bladder cancer were analyzed for tumor progression and recurrence. Only transurethral resection and/or fulguration was used before the first recurrence. Patients who received intravesical chemotherapy after the first tumor recurrence were excluded from an analysis of progression. Progression according to stages Ta and T1, and grades I, II and III was 4, 30, 2, 11 and 45 per cent, respectively. All differences were statistically significant. Progression also correlated with nontumor dysplasia and size. High tumor grade, lamina propria invasion, atypia elsewhere in the bladder, positive urinary cytology, tumor multiplicity and large tumors were associated with shorter intervals free of disease.

摘要

对249例最初表现为Ta期和T1期膀胱癌的患者的肿瘤进行了肿瘤进展和复发分析。首次复发前仅采用经尿道切除术和/或电灼术。首次肿瘤复发后接受膀胱内化疗的患者被排除在进展分析之外。根据Ta期和T1期以及I、II和III级的进展率分别为4%、30%、2%、11%和45%。所有差异均具有统计学意义。进展还与非肿瘤发育异常和大小相关。高肿瘤分级、固有层浸润、膀胱其他部位的异型性、尿细胞学阳性、肿瘤多发和大肿瘤与无病间隔时间较短有关。

相似文献

1
Superficial bladder cancer: progression and recurrence.浅表性膀胱癌:进展与复发
J Urol. 1983 Dec;130(6):1083-6. doi: 10.1016/s0022-5347(17)51695-x.
2
Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.无原位癌伴发的膀胱浅表性移行细胞癌膀胱内复发预测因素分析
Int J Urol. 2006 Nov;13(11):1389-92. doi: 10.1111/j.1442-2042.2006.01562.x.
3
Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.膀胱移行细胞癌的手术治疗。根治性手术的作用。
Saudi Med J. 2002 Jun;23(6):695-9.
4
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.低剂量卡介苗灌注治疗Ta3期膀胱肿瘤的复发、进展及疗效
J Urol. 2000 Jan;163(1):63-7.
5
Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.经尿道切除标本中的淋巴管浸润作为新诊断的T1期膀胱尿路上皮癌患者进展和转移的预测指标。
J Urol. 2009 Dec;182(6):2625-30. doi: 10.1016/j.juro.2009.08.083. Epub 2009 Oct 17.
6
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.膀胱T1期肿瘤患者接受膀胱内丝裂霉素治疗后重复经尿道切除术对复发率和进展率的影响:一项前瞻性随机临床试验。
J Urol. 2006 May;175(5):1641-4. doi: 10.1016/S0022-5347(05)01002-5.
7
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.复发性高危浅表性膀胱肿瘤患者根治性膀胱切除术的最佳时机。
BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x.
8
Prognostic factors in superficial bladder cancer.浅表性膀胱癌的预后因素。
Int Urol Nephrol. 1986;18(4):417-20. doi: 10.1007/BF02084112.
9
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.表浅性移行细胞膀胱癌的辅助化疗:一项欧洲癌症研究与治疗组织的随机试验的长期结果,该试验比较了阿霉素、环氧乳醚和单纯经尿道切除术。
J Urol. 1997 Aug;158(2):378-84. doi: 10.1016/s0022-5347(01)64484-7.
10
Multivariate analysis of the prognostic factors of primary superficial bladder cancer.原发性浅表性膀胱癌预后因素的多变量分析
J Urol. 2000 Jan;163(1):73-8. doi: 10.1016/s0022-5347(05)67975-x.

引用本文的文献

1
The Role of Bladder-Washing Cytology as an Adjunctive Method to Cystoscopy During Follow-Up for Low-Grade TaT1 Non-Muscle-Invasive Bladder Cancer.膀胱冲洗细胞学检查作为低级别TaT1非肌层浸润性膀胱癌随访期间膀胱镜检查辅助方法的作用
Cancers (Basel). 2024 Nov 1;16(21):3708. doi: 10.3390/cancers16213708.
2
Clinico-demographic Profile of Carcinoma Urinary Bladder-5-Year Experience from a Tertiary Care Centre of Eastern India.印度东部一家三级护理中心膀胱癌的临床人口统计学特征——5年经验
Indian J Surg Oncol. 2024 Jun;15(2):206-212. doi: 10.1007/s13193-023-01861-2. Epub 2023 Dec 15.
3
Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistance.
通过增殖必需基因特征进行预后和化疗反应预测:探究POLE2在膀胱癌进展和顺铂耐药中的作用
J Cancer. 2024 Feb 4;15(6):1734-1749. doi: 10.7150/jca.93023. eCollection 2024.
4
Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study.术前荧光原位杂交分析预测非肌肉浸润性膀胱癌患者肿瘤复发:一项双机构研究。
J Transl Med. 2023 Oct 2;21(1):685. doi: 10.1186/s12967-023-04528-2.
5
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.半乳糖凝集素-1和半乳糖凝集素-3表达在局限性膀胱尿路上皮癌中的预后价值
Transl Androl Urol. 2023 Feb 28;12(2):228-240. doi: 10.21037/tau-22-494. Epub 2023 Feb 7.
6
Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review.膀胱出口及尿道原发性黏液腺癌的影像学特征:病例报告及文献复习
Transl Cancer Res. 2022 Jul;11(7):2416-2424. doi: 10.21037/tcr-22-1547.
7
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.膀胱癌的分子肿瘤学:从起源到现代视角
Cancers (Basel). 2022 May 24;14(11):2578. doi: 10.3390/cancers14112578.
8
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy.雷帕霉素哺乳动物靶点(mTOR)复合物在膀胱癌进展和治疗中的新作用
Cancers (Basel). 2022 Mar 18;14(6):1555. doi: 10.3390/cancers14061555.
9
Direct Smear Versus Liquid-Based Cytology in the Diagnosis of Bladder Lesions.直接涂片与液基细胞学检查在膀胱病变诊断中的应用比较
Iran J Pathol. 2022 Winter;17(1):56-64. doi: 10.30699/IJP.2021.528171.2646. Epub 2021 Nov 15.
10
The Antitumor Effects of Plasma-Activated Saline on Muscle-Invasive Bladder Cancer Cells In Vitro and In Vivo Demonstrate Its Feasibility as a Potential Therapeutic Approach.血浆激活盐水对肌肉浸润性膀胱癌细胞的体内外抗肿瘤作用证明了其作为一种潜在治疗方法的可行性。
Cancers (Basel). 2021 Mar 2;13(5):1042. doi: 10.3390/cancers13051042.